ACE and Alzheimer disease: These findings are in line with a previous prospective cohort study conducted by Li et al. (2010) that reported reduced incidence and progression of AD in participants taking ARBs compared to those taking other cardiovascular drugs and a nested case–control analysis following AD patients who were prescribed different anti-hypertensive drugs including ACE-Is and ARBs (Davies et al., 2011).